Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
Annales De Biologie Clinique|January 1, 1988
[Biological monitoring of treatment with low molecular weight heparin]M Aiach, P Sié
Seminars in Thrombosis and Hemostasis|April 1, 1985
Practical considerations on the measurement of low molecular weight heparin anti-Xa activityM Aiach, M Roncato
Presse Medicale (Paris, France : 1983)|May 30, 1987
[Effect of a cyproterone-estradiol combination administered cutaneously on antithrombin III]C Jamin, M Aiach
Haemostasis|October 1, 1996
Molecular basis for protein C hereditary deficiencyM Aiach, S Gandrille
Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Genetic risk factors of thrombosis]J Emmerich, M Aiach
Annales Pharmaceutiques Francaises|January 1, 1996
[Exploration of hemostasis in current practice]M Aiach, P Gaussem
The New England Journal of Medicine|September 28, 1995
Mutation in the factor V gene and the risk of myocardial infarctionJ Emmerich, M Aiach
Presse Medicale (Paris, France : 1983)|May 30, 1987
[Does idiopathic venous thrombosis still exist?]J N Fiessinger, M Aiach
Gynecologie, Obstetrique & Fertilite|August 30, 2002
[Analytical choices for biological tests in thrombotic pathology]M Aiach, M Alhenc-Gelas
La Revue Du Praticien|May 21, 1985
[Low molecular weight heparin]M Aiach, J N Fiessinger
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Annales De Biologie Clinique|January 1, 1988
[Biological monitoring of treatment with low molecular weight heparin]M Aiach, P Sié
Seminars in Thrombosis and Hemostasis|April 1, 1985
Practical considerations on the measurement of low molecular weight heparin anti-Xa activityM Aiach, M Roncato
Presse Medicale (Paris, France : 1983)|May 30, 1987
[Effect of a cyproterone-estradiol combination administered cutaneously on antithrombin III]C Jamin, M Aiach
Haemostasis|October 1, 1996
Molecular basis for protein C hereditary deficiencyM Aiach, S Gandrille
Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Genetic risk factors of thrombosis]J Emmerich, M Aiach
Annales Pharmaceutiques Francaises|January 1, 1996
[Exploration of hemostasis in current practice]M Aiach, P Gaussem
The New England Journal of Medicine|September 28, 1995
Mutation in the factor V gene and the risk of myocardial infarctionJ Emmerich, M Aiach
Presse Medicale (Paris, France : 1983)|May 30, 1987
[Does idiopathic venous thrombosis still exist?]J N Fiessinger, M Aiach
Gynecologie, Obstetrique & Fertilite|August 30, 2002
[Analytical choices for biological tests in thrombotic pathology]M Aiach, M Alhenc-Gelas
La Revue Du Praticien|May 21, 1985
[Low molecular weight heparin]M Aiach, J N Fiessinger
Pageof 24